Safety and Efficacy of Darbepoetin Alfa in Previously Untreated Extensive-Stage Small-Cell Lung Cancer Treated With Platinum Plus EtoposidePIRKER, Robert; RAMLAU, Rodryg A; SCHUETTE, Wolfgang et al.Journal of clinical oncology. 2008, Vol 26, Num 14, pp 2342-2349, issn 0732-183X, 8 p.Article

Phase III Trial of Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care in Previously Treated Patients With Advanced Malignant Pleural MesotheliomaJASSEM, Jacek; RAMLAU, Rodryg; SANTORO, Armando et al.Journal of clinical oncology. 2008, Vol 26, Num 10, pp 1698-1704, issn 0732-183X, 7 p.Article

Randomized Phase III Trial Comparing Bexarotene (L1069-49)/Cisplatin/Vinorelbine With Cisplatin/Vinorelbine in Chemotherapy-Naive Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer : SPIRIT IRAMLAU, Rodryg; ZATLOUKAL, Petr; ZHANG, Joseph K et al.Journal of clinical oncology. 2008, Vol 26, Num 11, pp 1886-1892, issn 0732-183X, 7 p.Article

Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non-Small-Cell Lung CancerSEQUIST, Lecia V; VON PAWEL, Joachim; RAMLAU, Rodryg et al.Journal of clinical oncology. 2011, Vol 29, Num 24, pp 3307-3315, issn 0732-183X, 9 p.Article

Phase III Trial Comparing Vinflunine With Docetaxel in Second-Line Advanced Non-Small-Cell Lung Cancer Previously Treated With Platinum-Containing ChemotherapyKRZAKOWSKI, Maciej; RAMLAU, Rodryg; DELGADO, François M et al.Journal of clinical oncology. 2010, Vol 28, Num 13, pp 2167-2173, issn 0732-183X, 7 p.Article

AMG 386 in Combination With Sorafenib in Patients With Metastatic Clear Cell Carcinoma of the Kidney: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 StudyRINI, Brian; SZCZYLIK, Cezary; ROGOWSKI, Wojciech et al.Cancer. 2012, Vol 118, Num 24, pp 6152-6161, issn 0008-543X, 10 p.Article

Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life : A randomized controlled trialBELANI, Chandra P; PEREIRA, Jose R; MILLWARD, Michael et al.Lung cancer. 2006, Vol 53, Num 2, pp 231-239, issn 0169-5002, 9 p.Article

A Phase II Randomized Study of Cisplatin-Pemetrexed plus either Enzastaurin or Placebo in Chemonaive Patients with Advanced Non-Small Cell Lung CancerVANSTEENKISTE, Johan; RAMLAU, Rodryg; VON PAWEL, Joachim et al.Oncology. 2012, Vol 82, Num 1, pp 25-29, issn 0030-2414, 5 p.Article

Phase III study comparing oral topotecan to intravenous docetaxel in patients with pretreated advanced non-small-cell lung cancerRAMLAU, Rodryg; GERVAIS, Radj; SHEPHERD, Frances A et al.Journal of clinical oncology. 2006, Vol 24, Num 18, pp 2800-2807, issn 0732-183X, 8 p.Article

Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 Study GroupFOSSELLA, Frank; PEREIRA, Jose R; MILLWARD, Michael et al.Journal of clinical oncology. 2003, Vol 21, Num 16, pp 3016-3024, issn 0732-183X, 9 p.Article

Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non―Small-Cell Lung Cancer: A Randomized, Controlled Phase III TrialRAMLAU, Rodryg; GORBUNOVA, Vera; REY, Augustin et al.Journal of clinical oncology. 2012, Vol 30, Num 29, pp 3640-3647, issn 0732-183X, 8 p.Article

Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non-Small-Cell Lung Cancer : AVAiLRECK, Martin; VON PAWEL, Joachim; MANEGOLD, Christian et al.Journal of clinical oncology. 2009, Vol 27, Num 8, pp 1227-1234, issn 0732-183X, 8 p.Article

Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer : The tarceva lung cancer investigation trialPLUZANSKA, Anna; SZCZESNA, Aleksandra; JANASKOVA, Terezie et al.Journal of clinical oncology. 2007, Vol 25, Num 12, pp 1545-1552, issn 0732-183X, 8 p.Article

A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)WAKELEE, Heather A; MIDDLETON, Gary; DUNLOP, David et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 3, pp 815-824, issn 0344-5704, 10 p.Article

The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancerWAKELEE, Heather A; TAKIMOTO, Chris H; ZATLOUKAL, Petr et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 2, pp 563-571, issn 0344-5704, 9 p.Article

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer : A phase III trialBRODOWICZ, Thomas; KRZAKOWSKI, Maciej; JASSEM, Jacek et al.Lung cancer. 2006, Vol 52, Num 2, pp 155-163, issn 0169-5002, 9 p.Article

A phase II study of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer: clinical outcomes and quality of lifeJASSEM, Jacek; KRZAKOWSKI, Maciej; ROSZKOWSKI, Kazimierz et al.Lung cancer. 2002, Vol 35, Num 1, pp 73-79, issn 0169-5002Article

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non―Small-Cell Lung CancerSPIGEL, David R; ERVIN, Thomas J; GOVINDAN, Ramaswamy et al.Journal of clinical oncology. 2013, Vol 31, Num 32, pp 4105-4114, issn 0732-183X, 10 p.Conference Paper